The aim of this study was to develop and validate a competitive ELISA targeting a neo-epitope of COL6α3 and evaluate its associations with the gastrointestinal disorders UC, CD and CRC, in comparison to healthy controls. The gene discussed is COL6A3; the disease is colorectal carcinoma.